BREAST CANCER METASTATIC
Clinical trials for BREAST CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER METASTATIC trials appear
Sign up with your email to follow new studies for BREAST CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted pill slows BRCA breast cancer better than chemo
Disease control CompletedThis study tested a daily pill (olaparib) against standard chemotherapy in 302 people with metastatic breast cancer who have inherited BRCA1/2 mutations. The goal was to see if olaparib could delay cancer growth longer than chemo. Participants were randomly assigned to olaparib o…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 03:10 UTC
-
New combo therapy shows promise for Hard-to-Treat breast cancer
Disease control CompletedThis study tested a new treatment combination (SV-BR-1-GM plus retifanlimab) in 36 people with advanced breast cancer that had stopped responding to standard therapies. The goal was to see if the combination is safe and can shrink tumors. Participants received the treatment every…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New combo therapy shows promise for aggressive breast cancer
Disease control CompletedThis study tested two treatment approaches for people with advanced HR-positive, HER2-negative breast cancer that has spread. One group received a drug called abemaciclib plus hormone therapy, while the other got short-term chemotherapy followed by the same combo. The goal was to…
Matched conditions: BREAST CANCER METASTATIC
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated May 08, 2026 12:03 UTC